These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6723128

  • 1. Selected adverse reactions of D-penicillamine.
    Stein HB, Chalmers A, Schroeder ML, Dillon A.
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [Abstract] [Full Text] [Related]

  • 2. [Penicillamine-induced pemphigus].
    Kind P, Goerz G, Gleichmann E, Plewig G.
    Hautarzt; 1987 Sep; 38(9):548-52. PubMed ID: 3319968
    [Abstract] [Full Text] [Related]

  • 3. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F, Menkes CJ, Sainte-Croix A, Delbarre F, Babinet P, Chesneau AM.
    Nouv Presse Med; 1975 Nov 22; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M, Crouzet J, Homberg JC, Lessana M, Camus JP, Hewitt J.
    Nouv Presse Med; 1975 Dec 20; 4(44):3125-8. PubMed ID: 1220709
    [Abstract] [Full Text] [Related]

  • 8. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H, Job-Deslandre C, Delrieu F, Kahan A, Menkès CJ.
    Rev Rhum Mal Osteoartic; 1986 May 20; 53(5):341-4. PubMed ID: 3738397
    [Abstract] [Full Text] [Related]

  • 9. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K, Fabian F, Listewnik M.
    Z Rheumatol; 1981 May 20; 40(3):135-7. PubMed ID: 7282112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP, Homberg JC, Crouzet J, Mery C, Delrieu F, Massias P, Abuaf N.
    J Rheumatol Suppl; 1981 May 20; 7():80-3. PubMed ID: 6939887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP, Isaac G, Noël H, De Bruyère M, Huaux JP, Nagant de Deuxchaisnes C.
    Int J Clin Pharmacol Res; 1985 May 20; 5(3):143-7. PubMed ID: 4018948
    [Abstract] [Full Text] [Related]

  • 15. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB, Ruedy J, Atkins CJ, Offer RC.
    J Rheumatol; 1983 Apr 20; 10(2):319-22. PubMed ID: 6864688
    [Abstract] [Full Text] [Related]

  • 16. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D, Kommerell G.
    Klin Monbl Augenheilkd; 1976 Mar 20; 168(3):409-13. PubMed ID: 966573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ, Hashimoto F, Searles RP, Bankhurst AD.
    J Rheumatol; 1979 Mar 20; 6(2):237-9. PubMed ID: 458795
    [No Abstract] [Full Text] [Related]

  • 19. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC.
    Proc R Soc Med; 1977 Mar 20; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
    [No Abstract] [Full Text] [Related]

  • 20. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
    Ongerboer de Visser BW, van Soesbergen RM.
    Ned Tijdschr Geneeskd; 1978 Dec 30; 122(52):2055-8. PubMed ID: 732905
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.